Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever - 06/03/07
, Selime Ayaz d, Osman Yüksel e, Sedat Kiraz f, Ihsan Ertenli f, Meral Çalgüneri f
Corresponding author. Karargahtepe mahallesi, Kumrulu sokak, No: 18, Keçiören, Ankara, Turkey. Tel.: +90 312 3612568; fax: +90 312 3124120.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Aims |
To assess the levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with familial Mediterranean fever (FMF).
Methods |
Plasma levels of sVEGFR-1 were investigated in 33 FMF patients in an attack-free period (mean age 30.8years; males/females 10/23), in 15 patients with acute FMF attack (mean age 32.7years; males/females 7/8), and 19 healthy controls (mean age 32years; males/females 11/8). Levels of sVEGFR-1 were also compared among patients who were receiving colchicine and those who were not.
Results |
Plasma sVEGFR-1 levels were 3.49±1.10, 3.53±1.02, and 0.37±0.28ng/ml for FMF patients in the attack-free period, FMF patients with acute attack, and healthy controls, respectively. Plasma sVEGFR-1 levels were significantly higher in FMF patients with and without acute attack compared to the control group (p<0.05). sVEGFR-1 levels were not statistically significant between patients with acute attack and attack-free FMF patients (p>0.05). The plasma levels of sVEGFR-1 were also comparable in colchicine treated and untreated patients.
Conclusion |
Our data suggest that sVEGFR-1 may have a role in the ongoing inflammatory cascade in FMF.
Le texte complet de cet article est disponible en PDF.Keywords : Familial Mediterranean fever, VEGF, sVEGFR-1
Plan
Vol 74 - N° 1
P. 52-55 - janvier 2007 Retour au numéro
Article précédent
- Engraftment of cutaneous fibroblasts within synovial membrane in a nonhuman primate: Short-term results
- Natacha Bessis, Delphine Lemeiter, Liliane Laroche, Catherine Fournier, Tom Huizinga, Herbert Brok, Bert ‘t Hart, Marie-Christophe Boissier
- Long-term results of infliximab therapy in rheumatoid arthritis: Experience acquired by the North-Pas-de-Calais hospital network
- Vincent Ducoulombier, Elisabeth Solau, Pascal Coquerelle, Éric Houvenagel, Jean-Louis Siame, Xavier Desprez, Pierre Fauquert, Marie-Hélène Guyot, Bernard Delcambre, René-Marc Flipo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?